Omnicell (OMCL) Scheduled to Post Earnings on Thursday

Omnicell (NASDAQ:OMCL) is set to release its earnings data before the market opens on Thursday, May 2nd. Analysts expect Omnicell to post earnings of ($0.08) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings results on Thursday, February 8th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.22. The business had revenue of $258.85 million for the quarter, compared to analysts’ expectations of $256.00 million. Omnicell had a negative net margin of 1.78% and a positive return on equity of 3.43%. On average, analysts expect Omnicell to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Omnicell Stock Performance

Shares of OMCL opened at $27.40 on Tuesday. The company has a current ratio of 2.52, a quick ratio of 2.22 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $1.26 billion, a P/E ratio of -60.89 and a beta of 0.76. The firm’s fifty day simple moving average is $27.64 and its two-hundred day simple moving average is $32.04. Omnicell has a 12 month low of $25.69 and a 12 month high of $77.14.

Wall Street Analyst Weigh In

A number of brokerages have commented on OMCL. Benchmark cut their price target on shares of Omnicell from $42.00 to $38.00 and set a “buy” rating on the stock in a research report on Friday, February 9th. Barclays began coverage on shares of Omnicell in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $33.00 price target on the stock. Finally, Wells Fargo & Company cut their price target on shares of Omnicell from $28.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $42.20.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.